Company Filing History:
Years Active: 2004-2007
Title: Megan Sheehy: Innovator in Cell Lysis Detection
Introduction
Megan Sheehy is a prominent inventor based in Syracuse, NY (US). She has made significant contributions to the field of cell biology, particularly in the detection of specific cell lysis. With a total of 2 patents to her name, her work has implications for various applications in medical and biological research.
Latest Patents
Megan's latest patents focus on methods of detecting specific lysis of a cell by a lytic agent. The invention provides methods that involve contacting a labeled target cell with a lytic agent and detecting fluorescence in the target cell. The target cells are labeled with two fluorescent labels: one that labels the plasma membrane and another that labels the cytosol. The release of the cytosolic label from the target cell indicates that the target cell has been lysed. Additionally, the invention includes methods for detecting the presence of a cell or an antibody that specifically lyses a target cell, showcasing its utility in various applications.
Career Highlights
Megan Sheehy is associated with the J. David Gladstone Institutes, where she continues to advance her research in cell lysis detection. Her innovative approaches have garnered attention in the scientific community, contributing to the understanding of cellular interactions and responses.
Collaborations
Megan has collaborated with notable colleagues, including Douglas F. Nixon and Adrian B. McDermott. These collaborations have further enriched her research and expanded the impact of her inventions.
Conclusion
Megan Sheehy is a trailblazer in the field of cell biology, with her patents paving the way for advancements in detecting cell lysis. Her work exemplifies the importance of innovation in scientific research and its potential to improve our understanding of cellular processes.